Cargando…
GDC-0575, a CHK1 Inhibitor, Impairs the Development of Colitis and Colitis-Associated Cancer by Inhibiting CCR2(+) Macrophage Infiltration in Mice
BACKGROUND: Checkpoint kinase 1 (CHK1) plays an important role in DNA damage response and cell cycle progression. Thus, targeting CHK1 is an efficient strategy for cancer therapy. PURPOSE: The present study aimed to investigate the potential therapeutic effects of GDC-0575, a CHK1-specific inhibitor...
Autores principales: | Li, Min, Huang, Tianqing, Li, Xiaolan, Shi, Zhiwei, Sheng, Yue, Hu, Mimi, Song, Kui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058335/ https://www.ncbi.nlm.nih.gov/pubmed/33897258 http://dx.doi.org/10.2147/OTT.S297132 |
Ejemplares similares
-
The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis
por: Pei, Xiaolei, et al.
Publicado: (2017) -
CCR9 Antagonists in the Treatment of Ulcerative Colitis
por: Bekker, Pirow, et al.
Publicado: (2015) -
Antiproton-proton total cross-sections between 0.575 and 5.35 GeV/c
por: Amaldi, Ugo, et al.
Publicado: (1964) -
Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer
por: Zhang, Maorun, et al.
Publicado: (2023) -
Shared biomarkers and immune cell infiltration signatures in ulcerative colitis and nonalcoholic steatohepatitis
por: Wang, Wenxin, et al.
Publicado: (2023)